SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alchemy Pay

Alchemy Pay is trending amid strong community debate, fueled by recent developments including new Money Transmitter Licenses, expanding fiat on-ramps for major stablecoins like Ripple's RLUSD, and the introduction of tokenized stock access. Many see it as a "sleeping giant" poised for a significant structural upgrade with its evolving Alchemy Chain, while others remain skeptical, viewing it as a "pump and dump" despite its growing global payment utility.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MULN CRYPTO is trending amidst highly polarized community sentiment, with many investors connecting the token to the controversial history of the original Mullen Automotive stock, citing past dilution and alleged misleading practices. While a "Mullen Army" promotes the token as a community-driven project with utility, a dominant conversation points to concerns about it being a "scam coin" or "rug pull" due to extremely low trading activity and perceived lack of intrinsic value. The narrative is heavily influenced by ongoing discussions around a class-action settlement related to the stock's history, fueling widespread skepticism.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is gaining significant attention due to its prominent partnership with World Liberty Finance and the impending rollout of its Super App, alongside confirmed integration with Stellar and ongoing discussions with Ripple. The community is highly optimistic, emphasizing ZBCN's robust real-world utility in payment and payroll infrastructure, its ISO 20022 and MiCA compliance, and its potential to become a foundational project in the real-world asset (RWA) sector. Many foresee substantial long-term growth, comparing its current positioning to that of early major cryptocurrencies.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending due to recent positive advancements in its HIV pipeline, including favorable trial results for a new regimen and extending market exclusivity for a leading therapy. This comes as the company continues to strategically bolster its oncology and antiviral assets, driving increased analyst interest and discussions around its diversified growth trajectory.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

BNB is generating significant buzz due to the recent pardon of Binance founder CZ, which has ignited fresh optimism within the community. Traders are closely monitoring technical indicators, actively discussing potential price rallies and short-term movements. This renewed interest is further amplified by ongoing ecosystem developments, such as new integrations and consistent token burns, reinforcing BNB's utility.

BlackPearl.Chain is pushing decentralization into the future with a third-generation public blockchain. It’s network achieves blazing transaction speeds (Millions TPS) using Sharding and a VRF lightning-fast consensus mechanism built in-house. Finality is achieved in under three seconds with revolutionary P2P, Its speed and security make it the perfect platform for applications like digital asset trading, social media messaging, payment processing, supply chain tracking, and other high-scale use cases.

BlackPearl

The BPLC crypto community is highly optimistic about its long-term potential, with many envisioning it as a future "game changer" in commerce. Enthusiastic investors are comparing it to established digital assets like XRP, eagerly anticipating mainstream exchange adoption and significant market cap expansion.

Blacksky Technology, Inc. is a space-based intelligence company, which engages in the business of delivering real-time imagery, analytics, and high-frequency monitoring of most critical and strategic locations, economic assets, and events. The firm is also involved in providing geospatial intelligence, imagery and related data analytic products and services, and mission systems that include the development, integration, and operation of satellite and ground systems to government and commercial customers. The company was founded in 2014 and is headquartered in Herndon, VA.

BlackSky Technology Inc - Ordinary Shares - Class A

BlackSky Technology is trending following a bullish analyst initiation and a significant new multi-year international defense contract, positioning it as a key player in the rapidly expanding space and defense intelligence sector. Community discussion highlights the company's advanced AI-enabled, high-resolution satellite imagery for tactical military use and its significant long-term growth potential, despite ongoing conversations about satellite launch timelines and market volatility.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending following mixed reactions to interim Phase 2 data for its cystic fibrosis therapy, ARCT-032, leading to significant volatility as some view the stock's sharp decline as an overreaction to early biological activity like mucus plug reduction. The community is actively discussing the potential of higher dose cohorts, progress in their OTC deficiency program, and an ongoing trade secret lawsuit against AbbVie, all while anticipating future pipeline developments and a potential short squeeze.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian ($TEAM) is trending as the broader software sector experiences significant pressure, driven by fears of AI disruption to core offerings like Jira and Confluence. While many in the community perceive the downturn as an overreaction and a buying opportunity given the company's solid fundamentals and AI integration efforts, concerns about continued weakness and insider selling persist among others.

Avino Silver & Gold Mines Ltd. engages in the mining and exploration activities. It focuses on silver reserves in the Durango region of North Central Mexico. It operates through the Silver, Gold, and Copper segments. The company was founded on May 15, 1968 and is headquartered in Vancouver, Canada.

Avino Silver & Gold Mines Ltd.

Avino Silver & Gold Mines is currently trending amidst widespread bullish sentiment for precious metals, with many in the community anticipating a significant silver price breakout driven by physical demand and perceived market manipulation. Investors are keenly focused on ASM's strong operational performance, upcoming La Preciosa project developments, and solid earnings, expecting a substantial re-rating for the stock to reflect surging metal prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Intellia Therapeutics (NASDAQ:NTLA) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen cut shares of Intellia Therapeutics from a "hold" rating to a "sell" rating in a report on Sunday...

Sumitomo Mitsui Trust Group Inc. Sells 316,409 Shares of Intellia Therapeutics, Inc. $NTLA

Sumitomo Mitsui Trust Group Inc. decreased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 11.8% in the 3rd quarter, according to the company in its most recent 13F filing...

<ul class="summary-bullets"><li>Geopolitical tensions, questions around Federal Reserve independence, and selective earnings reactions remain key sentiment drivers.</li><li>Sentiment around the Invesco QQQ Trust (QQQ) cooled to&nbsp;neutral from bullish a day earlier on Stocktwits, alongside elevated message volumes.</li></ul>U.S. stock futures&nbsp;were trading higher early Friday, with markets looking to build on the gains in the previous session. The geopolitical risks in Iran and Greenland, along with chatter about perceived threats to Fed independence, will weigh on market sentiment ahead of a long weekend. U.S. markets will be shut on Monday.&nbsp;As of 4:15 a.m. ET on Thursday, the S&amp;P 500 futures were up 0.2%, the Nasdaq 100 futures gained 0.4%, while the Dow futures were up 0.1%, and Russell 2000 futures traded 0.3% higher.On Stocktwits, meanwhile, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, has remained ‘bullish’. While sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, has moved to ‘neutral’ from ‘bullish’ a day ago, amid high message volumes.&nbsp;Trending Stocks To Watch J.B. Hunt (JBHT): Tumbled in after-hours trading after missing earnings estimates, citing a continued ‘freight recession’ in the US.Micron (MU): The stock is back on retail radar, driven by an&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/micron-stock-climbs-after-hours-on-insider-buy/cmUlXYOR4Jn">insider purchase</a> and bullish analyst actions.Intellia Therapeutics (NTLA): Cathie Wood’s ARK exchange-traded funds only made one trade on Thursday: buying more of Intellia Therapeutics, whose shares are heading for their best week since October.AST Spacemobile (ASTS): The stock is garnering retail attention, driven by buzz around a 'Golden Dome' defense order. It is on track for third straight weekly close.&nbsp;Watch out for hyperscalers such as Amazon (AMZN), Microsoft (MSFT), and Google (GOOGL): Reports suggest that Trump and several Northeast governors are pushing PJM, the nation’s largest grid operator, to run an emergency ‘reliability’ auction that would let companies bid for 15-year contracts tied to building new generation.Talen Energy (TLN): The stock rallied on Thursday after it said it will acquire Pennsylvania-New Jersey-Maryland Interconnection (PJM) natural gas assets from Energy Capital Partners.&nbsp;Walmart, Inc (WMT): Kathryn McLay, the CEO of the retailer’s international business, is&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/walmart-stock-holds-firm-as-international-chief-steps-down/cmUliBOR4J8">stepping</a> down from her role at the end of this month.&nbsp;Other tickers trending on Stocktwits at the time of writing included Springview Holdings (SPHL), Regentis Biomaterial (RGNT), Reddit (RDDT), Sandish (SNDK), and Super Micro Computer (SMCI), among others.&nbsp; Other Catalysts To Watch On the economic front, no notable release is expected. Investors will be watching commentary from a few Fed speakers, including Michele Bowman, later today.&nbsp; On the earnings radar, investors will also be watching for the quarterly report from&nbsp;PNC Financial (PNC), State Street (STT), M&amp;T Bank (MTB), Citizens Financial (CFG), and Regions Financial (RF).For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today

Retail sentiment on Stocktwits remains bullish on the S&P 500, even as macro risks linger. Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today.

Equity

Retail sentiment on Stocktwits remains bullish on the S&P 500, even as macro risks linger. 


Cathie Wood, Founder & CEO, Ark Invest, speaks during the second day of the FII PRIORITY Summit

Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD

ARK doubles down on a CRISPR bet as Intellia Therapeutics’ stock heads for its best week since October.

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives Average Recommendation of "Hold" from Brokerages

Intellia Therapeutics, Inc. (NASDAQ:NTLA - Get Free Report) has been given a consensus rating of "Hold" by the twenty-two ratings firms that are currently covering the firm, Marketbeat reports. Three...

Intellia Therapeutics, Inc. (NTLA) Recently Broke Out Above the 200-Day Moving Average

Should investors be excited or worried when a stock crosses above the 200-day simple moving average?

Intellia CEO Sells $314K in Stock While Holding Over 1 Million Shares

Key PointsThe president and CEO of Intellia Therapeutics sold 34,146 directly held shares of the firm on Jan. 5...

Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Up - Time to Buy?

Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Up - What's Next...

Intellia Stock Declines Around 55% in 3 Months: Here's Why

NTLA shares plunge 55% in three months after the FDA placed a clinical hold on Nex-Z, suspending trials and milestone guidance following the death of a patient.

Cathie Wood shells out $1.3 million on biotech stock

On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics (NTLA), scooping up 145,153 shares in the gene-editing play. For the most part, it...

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Current Price	$12.50
Prev Close	$11.87
Open	$11.88
Dividend Yield	0.00%
50-Day Moving Average	$9.58
Beta	1.73
Avg. Volume	3.5M
PE Ratio	-2.93

52-Week High	$28.25
52-Week Low	$5.90
Market Capitalization	$1.45B
EPS (Annual)	-$5.25
Price to Book	1.93
Revenue Per Employee	$143,615.39
Enterprise Value/EBITDA	N/A

NTLA
Intellia Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NTLA News

NTLAIntellia Therapeutics Inc